Consistent with this, co-administration of the GLP-2R agonist h(Gly 2 )GLP-2 and exendin-4 increases small intestinal weight and length to a greater extent compared to the agonists administered alone (Koehler et al., 2015)
When to Speak to Your Doctor About Your Progress Contact your doctor if you experience persistent gastrointestinal symptoms, signs of pancreatitis or dehydration, gallbladder symptoms, hypoglycaemia, or unexplained palpitations
Two potent therapeutic strategies based on the GLP-1 system have been developed for the treatment of type 2 diabetes [1]
Researchers can explore additional information through our Retatrutide Research Knowledge Hub , which provides educational resources on peptide structure, research topics, and laboratory handling
May support recovery following cosmetic treatments or minor skin trauma